PRTA Latest Press Releases

-- March 21, 2026 --

Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson's and Alzheimer's Disease at AD/PD 2026 Business Wire 4:05 PM

-- March 9, 2026 --

Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy Business Wire 4:05 PM

-- February 27, 2026 --

Prothena Announces up to $100 Million Share Repurchase Plan Business Wire 4:15 PM

-- February 19, 2026 --

Prothena Reports Fourth Quarter and Full Year 2025 Financial Results, and Provides Financial Guidance and Business Highlights Business Wire 4:05 PM

-- February 12, 2026 --

Prothena to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 Business Wire 4:05 PM

-- December 12, 2025 --

Prothena Announces Board of Directors Update Business Wire 4:05 PM

-- November 19, 2025 --

Prothena Announces Poster Presentation on its TDP-43 CYTOPE Program at Neuroscience 2025 Business Wire 4:05 PM

-- November 11, 2025 --

Prothena Highlights Phase 2 Data for Coramitug (Formerly PRX004) Published in Circulation, Official Journal of AHA Business Wire 9:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software